About EKR Therapeutics

Headquartered in Bedminster, New Jersey, EKR Therapeutics is a specialty pharmaceutical company focused on the acute-care hospital setting.  EKR is committed to serving the needs of this important segment of the healthcare market by providing novel products offering broader therapeutic potential and superior outcomes.  

Founded in late 2005 by veteran healthcare and business executives, EKR has brought together a highly cohesive team of pharmaceutical professionals with established records of accomplishments in acute care.  Many have previously collaborated in successfully applying the EKR growth strategy.  The ongoing strength and dedication of the EKR talent pool is evident in EKR’s growth from a start up situation to a viable and profitable commercial company within two years of initiating operations. 

EKR has been organized from its inception to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products.  To this end, the Company actively pursues opportunities to identify and foster the growth of specialty products that can significantly benefit from EKR’s knowledge and commercial strengths in the acute-care space. 

Supported by the strengths of its management team, the experience of its field force of product specialists, and a commitment to excellence in customer service and medical education, EKR’s goal is nothing less than pre-eminence as a provider of acute-care specialty products.